Key facts
- It has raised $130K; the latest was Seed Round ($130K) in Mar 2025.
- Notable investors include Glocalink, KicSpace, Sagamihara Incubation Center, Tech Planter.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for NERON
- ·The full record, as it builds
Funding rounds
No funding rounds for NERON are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NERON
Developer of gut microbiome therapeutics designed to support mental and physical health through the gut-brain axis. The company offers proprietary gut microbiome cocktails formulated through microbiome profiling, strain selection, and gut-brain axis research, enabling individuals seeking relief from anxiety, stress, and broader health challenges to support both mental resilience and overall physiological well-being with science-based interventions.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2022
- Employees
- 3
- Website
- neron.jp/
- Ownership
- Privately Held (backing)
NERON doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NERON shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NERON in its N-PORT filings yet. We sweep new filings monthly.